Table 2 |
|||
|
Retention times, MRM transitions and ESI conditions of analytes. |
|||
|
Analytes |
Retention time (min) |
Transition (m/z) Precursor→ Product |
Collision energy (eV) |
|
|
|||
|
401.3 → 383.1 |
36 |
||
|
25OHD3 |
13.5 |
401.3 → 365.1 |
41 |
|
401.3 → 159.2 |
46 |
||
|
413.3 → 395.5 |
46 |
||
|
25OHD2 |
11.1 |
413.3 → 377.2 |
51 |
|
413.3 → 355.5 |
53 |
||
|
401.3 → 383.1 |
36 |
||
|
3-epi-25OHD3 |
13.1 |
401.3 → 365.1 |
41 |
|
401.3 → 159.2 |
46 |
||
|
401.3 → 383.1 |
36 |
||
|
1αOHD3 |
11.1 |
401.3 → 365.1 |
41 |
|
401.3 → 159.2 |
46 |
||
|
401.3 → 383.1 |
36 |
||
|
7αC4 |
10.5 |
401.3 → 365.1 |
41 |
|
401.3 → 159.2 |
46 |
||
|
Stanozolol-D3 (I.S) |
3.09 |
332.2 → 81.2 |
42 |
|
|
|||
|
Shah et al. Nutrition Journal 2011 10:46 doi:10.1186/1475-2891-10-46 |
|||